Q2-4: Survival

!The following questions will only be enabled if the cell therapy was reported on the Pre-Cellular Therapy Baseline Data (4001) form as planned as outpatient and can only be completed on the 100-day follow-up form. These questions will be skipped for all subsequent reporting periods.

Question 2: Was the recipient admitted to the hospital post-infusion?

The practice of outpatient cellular therapy infusions is increasing however there might still be the need for admission for cellular therapy toxicities. In order to capture if patients require admission following cellular therapy a date of admission and discharge will be collected.

Question 3: Date of first hospital admission:

Report the first date (YYYY-MM-DD) the recipient was admitted to the hospital post-infusion.

For more information regarding reporting partial or unknown dates, see General Instructions, General Guidelines for Completing Forms.

Question 4: Date of first discharge:

Report the date (YYYY-MM-DD) of first discharge after the first hospital admission.

For more information regarding reporting partial or unknown dates, see General Instructions, General Guidelines for Completing Forms.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.